Clinical Decision Support Tools for Antibiotic Prescribing

Infectious Disease Clinical Trial

Official title:

The Effect of Data Visualization on Provider Knowledge of Culture Sensitivity Results

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03580603
• Other study ID #: 2017P000432
• Secondary ID: 2017P000432
• Status: Completed
• Phase: N/A
• Start date: March 5, 2018
• Est. completion date: September 30, 2018

Study information

• Verified date: May 2021
• Source: Beth Israel Deaconess Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions regarding past sensitivity results. They will be randomized to either using the visualization tool before answering the questions or using the standard medical record tools. They will then be surveyed about their decision-making, knowledge, and the usefulness of the tool.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 273
• Est. completion date: September 30, 2018
• Est. primary completion date: September 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• provider is caring for a patient with a previous positive urine or blood cultures

• provider is caring for a patient currently in a clinical location being investigated

• provider is caring for a patient with orders placed for an intravenous, intramuscular, oral antibiotics

Exclusion Criteria:

• the patient has already received the antibiotic by the time of the intervention

• the antibiotic has been cancelled by the time of intervention

• the research assistant is unable to reach the ordering provider before the visit is completed

• participation by the clinician in the study would impede clinical care

• age < 18

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Infectious Disease

Intervention

Other:
• Visualization tool
Visual representation of past microbiological culture data

Locations

Country	Name	City	State
United States	Beth Israel Deaconess Medical Center	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Beth Israel Deaconess Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Provider knowledge	Provider knowledge of patients' previous culture sensitivity results as determined by the proportion of correct answers on a questionnaire: Do you think this patient has had previous resistance to each of these antibiotics at BIDMC (Beth Israel Deaconess Medical Center)?; [List of the top 4 antibiotic classes to which resistance is seen at BIDMC that the patient has previously had tested for antibiotic sensitivities]; Yes (previous organisms resistant or with intermediate resistance); No (no previous resistance noted)	To be assessed at the time of patient enrollment, up to one day after the initial antibiotic is ordered.
Secondary	Post-intervention survey	Providers will be asked survey questions regarding their decision-making and the usability and usefulness of the tool using a 5 point Likert scale: I understand the previous culture data for this patient (Strongly disagree) 1 2 3 4 5 (Strongly agree); I feel like I made an informed antibiotic choice (Strongly disagree) 1 2 3 4 5 (Strongly agree); The tool provided new information that you were not previously aware of (Strongly disagree) 1 2 3 4 5 (Strongly agree); The tool enabled you to more quickly understand this patient's microbiological data (Strongly disagree) 1 2 3 4 5 (Strongly agree); The tool was easy to use (Strongly disagree) 1 2 3 4 5 (Strongly agree)	To be assessed at the time of patient enrollment, up to one day after the initial antibiotic is ordered.
Secondary	Antibiotic order changes	Antibiotic orders that are not complete by the time of the intervention will be monitored for any cancellation or change in orders	To be assessed at the time of patient enrollment + 1 day
Secondary	Final culture results	Final culture results drawn from that visit will be compared to antibiotic orders for effectiveness	To be assessed at the time of patient enrollment + 1 week